Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global RNAi for Therapeutic Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

  • MAI4656886
  • 122 Pages
  • October 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of gene expression. The notion that RNAi could lead to a new class of therapeutics caught the attention of many investigators soon after its discovery. The field of applied RNAi therapeutics has moved very quickly from lab to bedside. The RNAi approach has been widely used for drug development and several phase I and II clinical trials are under way. However, there are still some concerns and challenges to overcome for therapeutic applications. These include the potential for off-target effects, triggering innate immune responses and most importantly obtaining specific delivery into the cytoplasm of target cells.

Based on the RNAi for Therapeutic market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global RNAi for Therapeutic market covered in Chapter 5:

RXi Pharmaceuticals

CombiMatrix

Benitec Biopharma

Astellas Pharma

Quark Pharmaceuticals

Tekmira Pharmaceuticals.

Biogazelle

Bayer Heathcare

AstraZeneca

Arrowhead Research

Gradalis Incorporated

Silenseed

Silence Therapeutics

Ensysce Biosciences

GeneCopoeia

Creative Animodel

Alnylam Pharmaceuticals

Roche Innovation Center Copenhagen (formerly Santaris Pharma)

Ascletis Pharmaceuticals

Sylentis

Celsion Corporation

Calando Pharmaceuticals

Celgene

BioSpring

In Chapter 6, on the basis of types, the RNAi for Therapeutic market from 2015 to 2025 is primarily split into:

siRNA

miRNA

shRNA

In Chapter 7, on the basis of applications, the RNAi for Therapeutic market from 2015 to 2025 covers:

Cancer

Cardiovascular

HBV

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global RNAi for Therapeutic Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 RXi Pharmaceuticals

5.1.1 RXi Pharmaceuticals Company Profile

5.1.2 RXi Pharmaceuticals Business Overview

5.1.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.1.4 RXi Pharmaceuticals RNAi for Therapeutic Products Introduction

5.2 CombiMatrix

5.2.1 CombiMatrix Company Profile

5.2.2 CombiMatrix Business Overview

5.2.3 CombiMatrix RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.2.4 CombiMatrix RNAi for Therapeutic Products Introduction

5.3 Benitec Biopharma

5.3.1 Benitec Biopharma Company Profile

5.3.2 Benitec Biopharma Business Overview

5.3.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.3.4 Benitec Biopharma RNAi for Therapeutic Products Introduction

5.4 Astellas Pharma

5.4.1 Astellas Pharma Company Profile

5.4.2 Astellas Pharma Business Overview

5.4.3 Astellas Pharma RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.4.4 Astellas Pharma RNAi for Therapeutic Products Introduction

5.5 Quark Pharmaceuticals

5.5.1 Quark Pharmaceuticals Company Profile

5.5.2 Quark Pharmaceuticals Business Overview

5.5.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.5.4 Quark Pharmaceuticals RNAi for Therapeutic Products Introduction

5.6 Tekmira Pharmaceuticals.

5.6.1 Tekmira Pharmaceuticals. Company Profile

5.6.2 Tekmira Pharmaceuticals. Business Overview

5.6.3 Tekmira Pharmaceuticals. RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.6.4 Tekmira Pharmaceuticals. RNAi for Therapeutic Products Introduction

5.7 Biogazelle

5.7.1 Biogazelle Company Profile

5.7.2 Biogazelle Business Overview

5.7.3 Biogazelle RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.7.4 Biogazelle RNAi for Therapeutic Products Introduction

5.8 Bayer Heathcare

5.8.1 Bayer Heathcare Company Profile

5.8.2 Bayer Heathcare Business Overview

5.8.3 Bayer Heathcare RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.8.4 Bayer Heathcare RNAi for Therapeutic Products Introduction

5.9 AstraZeneca

5.9.1 AstraZeneca Company Profile

5.9.2 AstraZeneca Business Overview

5.9.3 AstraZeneca RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.9.4 AstraZeneca RNAi for Therapeutic Products Introduction

5.10 Arrowhead Research

5.10.1 Arrowhead Research Company Profile

5.10.2 Arrowhead Research Business Overview

5.10.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.10.4 Arrowhead Research RNAi for Therapeutic Products Introduction

5.11 Gradalis Incorporated

5.11.1 Gradalis Incorporated Company Profile

5.11.2 Gradalis Incorporated Business Overview

5.11.3 Gradalis Incorporated RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.11.4 Gradalis Incorporated RNAi for Therapeutic Products Introduction

5.12 Silenseed

5.12.1 Silenseed Company Profile

5.12.2 Silenseed Business Overview

5.12.3 Silenseed RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.12.4 Silenseed RNAi for Therapeutic Products Introduction

5.13 Silence Therapeutics

5.13.1 Silence Therapeutics Company Profile

5.13.2 Silence Therapeutics Business Overview

5.13.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.13.4 Silence Therapeutics RNAi for Therapeutic Products Introduction

5.14 Ensysce Biosciences

5.14.1 Ensysce Biosciences Company Profile

5.14.2 Ensysce Biosciences Business Overview

5.14.3 Ensysce Biosciences RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.14.4 Ensysce Biosciences RNAi for Therapeutic Products Introduction

5.15 GeneCopoeia

5.15.1 GeneCopoeia Company Profile

5.15.2 GeneCopoeia Business Overview

5.15.3 GeneCopoeia RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.15.4 GeneCopoeia RNAi for Therapeutic Products Introduction

5.16 Creative Animodel

5.16.1 Creative Animodel Company Profile

5.16.2 Creative Animodel Business Overview

5.16.3 Creative Animodel RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.16.4 Creative Animodel RNAi for Therapeutic Products Introduction

5.17 Alnylam Pharmaceuticals

5.17.1 Alnylam Pharmaceuticals Company Profile

5.17.2 Alnylam Pharmaceuticals Business Overview

5.17.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.17.4 Alnylam Pharmaceuticals RNAi for Therapeutic Products Introduction

5.18 Roche Innovation Center Copenhagen (formerly Santaris Pharma)

5.18.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Company Profile

5.18.2 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Business Overview

5.18.3 Roche Innovation Center Copenhagen (formerly Santaris Pharma) RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.18.4 Roche Innovation Center Copenhagen (formerly Santaris Pharma) RNAi for Therapeutic Products Introduction

5.19 Ascletis Pharmaceuticals

5.19.1 Ascletis Pharmaceuticals Company Profile

5.19.2 Ascletis Pharmaceuticals Business Overview

5.19.3 Ascletis Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.19.4 Ascletis Pharmaceuticals RNAi for Therapeutic Products Introduction

5.20 Sylentis

5.20.1 Sylentis Company Profile

5.20.2 Sylentis Business Overview

5.20.3 Sylentis RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.20.4 Sylentis RNAi for Therapeutic Products Introduction

5.21 Celsion Corporation

5.21.1 Celsion Corporation Company Profile

5.21.2 Celsion Corporation Business Overview

5.21.3 Celsion Corporation RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.21.4 Celsion Corporation RNAi for Therapeutic Products Introduction

5.22 Calando Pharmaceuticals

5.22.1 Calando Pharmaceuticals Company Profile

5.22.2 Calando Pharmaceuticals Business Overview

5.22.3 Calando Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.22.4 Calando Pharmaceuticals RNAi for Therapeutic Products Introduction

5.23 Celgene

5.23.1 Celgene Company Profile

5.23.2 Celgene Business Overview

5.23.3 Celgene RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.23.4 Celgene RNAi for Therapeutic Products Introduction

5.24 BioSpring

5.24.1 BioSpring Company Profile

5.24.2 BioSpring Business Overview

5.24.3 BioSpring RNAi for Therapeutic Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.24.4 BioSpring RNAi for Therapeutic Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global RNAi for Therapeutic Sales and Market Share by Types (2015-2020)

6.1.2 Global RNAi for Therapeutic Revenue and Market Share by Types (2015-2020)

6.1.3 Global RNAi for Therapeutic Price by Types (2015-2020)

6.2 Global RNAi for Therapeutic Market Forecast by Types (2020-2025)

6.2.1 Global RNAi for Therapeutic Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global RNAi for Therapeutic Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global RNAi for Therapeutic Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global RNAi for Therapeutic Sales, Price and Growth Rate of siRNA

6.3.2 Global RNAi for Therapeutic Sales, Price and Growth Rate of miRNA

6.3.3 Global RNAi for Therapeutic Sales, Price and Growth Rate of shRNA

6.4 Global RNAi for Therapeutic Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 siRNA Market Revenue and Sales Forecast (2020-2025)

6.4.2 miRNA Market Revenue and Sales Forecast (2020-2025)

6.4.3 shRNA Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global RNAi for Therapeutic Sales and Market Share by Applications (2015-2020)

7.1.2 Global RNAi for Therapeutic Revenue and Market Share by Applications (2015-2020)

7.2 Global RNAi for Therapeutic Market Forecast by Applications (2020-2025)

7.2.1 Global RNAi for Therapeutic Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global RNAi for Therapeutic Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global RNAi for Therapeutic Revenue, Sales and Growth Rate of Cancer (2015-2020)

7.3.2 Global RNAi for Therapeutic Revenue, Sales and Growth Rate of Cardiovascular (2015-2020)

7.3.3 Global RNAi for Therapeutic Revenue, Sales and Growth Rate of HBV (2015-2020)

7.3.4 Global RNAi for Therapeutic Revenue, Sales and Growth Rate of Others (2015-2020)

7.4 Global RNAi for Therapeutic Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Cancer Market Revenue and Sales Forecast (2020-2025)

7.4.2 Cardiovascular Market Revenue and Sales Forecast (2020-2025)

7.4.3 HBV Market Revenue and Sales Forecast (2020-2025)

7.4.4 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global RNAi for Therapeutic Sales by Regions (2015-2020)

8.2 Global RNAi for Therapeutic Market Revenue by Regions (2015-2020)

8.3 Global RNAi for Therapeutic Market Forecast by Regions (2020-2025)

9 North America RNAi for Therapeutic Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

9.3 North America RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

9.4 North America RNAi for Therapeutic Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America RNAi for Therapeutic Market Analysis by Country

9.6.1 U.S. RNAi for Therapeutic Sales and Growth Rate

9.6.2 Canada RNAi for Therapeutic Sales and Growth Rate

9.6.3 Mexico RNAi for Therapeutic Sales and Growth Rate

10 Europe RNAi for Therapeutic Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

10.3 Europe RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

10.4 Europe RNAi for Therapeutic Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe RNAi for Therapeutic Market Analysis by Country

10.6.1 Germany RNAi for Therapeutic Sales and Growth Rate

10.6.2 United Kingdom RNAi for Therapeutic Sales and Growth Rate

10.6.3 France RNAi for Therapeutic Sales and Growth Rate

10.6.4 Italy RNAi for Therapeutic Sales and Growth Rate

10.6.5 Spain RNAi for Therapeutic Sales and Growth Rate

10.6.6 Russia RNAi for Therapeutic Sales and Growth Rate

11 Asia-Pacific RNAi for Therapeutic Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific RNAi for Therapeutic Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific RNAi for Therapeutic Market Analysis by Country

11.6.1 China RNAi for Therapeutic Sales and Growth Rate

11.6.2 Japan RNAi for Therapeutic Sales and Growth Rate

11.6.3 South Korea RNAi for Therapeutic Sales and Growth Rate

11.6.4 Australia RNAi for Therapeutic Sales and Growth Rate

11.6.5 India RNAi for Therapeutic Sales and Growth Rate

12 South America RNAi for Therapeutic Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

12.3 South America RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

12.4 South America RNAi for Therapeutic Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America RNAi for Therapeutic Market Analysis by Country

12.6.1 Brazil RNAi for Therapeutic Sales and Growth Rate

12.6.2 Argentina RNAi for Therapeutic Sales and Growth Rate

12.6.3 Columbia RNAi for Therapeutic Sales and Growth Rate

13 Middle East and Africa RNAi for Therapeutic Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa RNAi for Therapeutic Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa RNAi for Therapeutic Market Analysis by Country

13.6.1 UAE RNAi for Therapeutic Sales and Growth Rate

13.6.2 Egypt RNAi for Therapeutic Sales and Growth Rate

13.6.3 South Africa RNAi for Therapeutic Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global RNAi for Therapeutic Market Size and Growth Rate 2015-2025

Table RNAi for Therapeutic Key Market Segments

Figure Global RNAi for Therapeutic Market Revenue ($) Segment by Type from 2015-2020

Figure Global RNAi for Therapeutic Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of RNAi for Therapeutic

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table RXi Pharmaceuticals Company Profile

Table RXi Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure RXi Pharmaceuticals Production and Growth Rate

Figure RXi Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table CombiMatrix Company Profile

Table CombiMatrix Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure CombiMatrix Production and Growth Rate

Figure CombiMatrix Market Revenue ($) Market Share 2015-2020

Table Benitec Biopharma Company Profile

Table Benitec Biopharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Benitec Biopharma Production and Growth Rate

Figure Benitec Biopharma Market Revenue ($) Market Share 2015-2020

Table Astellas Pharma Company Profile

Table Astellas Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Astellas Pharma Production and Growth Rate

Figure Astellas Pharma Market Revenue ($) Market Share 2015-2020

Table Quark Pharmaceuticals Company Profile

Table Quark Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Quark Pharmaceuticals Production and Growth Rate

Figure Quark Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Tekmira Pharmaceuticals. Company Profile

Table Tekmira Pharmaceuticals. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Tekmira Pharmaceuticals. Production and Growth Rate

Figure Tekmira Pharmaceuticals. Market Revenue ($) Market Share 2015-2020

Table Biogazelle Company Profile

Table Biogazelle Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Biogazelle Production and Growth Rate

Figure Biogazelle Market Revenue ($) Market Share 2015-2020

Table Bayer Heathcare Company Profile

Table Bayer Heathcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer Heathcare Production and Growth Rate

Figure Bayer Heathcare Market Revenue ($) Market Share 2015-2020

Table AstraZeneca Company Profile

Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AstraZeneca Production and Growth Rate

Figure AstraZeneca Market Revenue ($) Market Share 2015-2020

Table Arrowhead Research Company Profile

Table Arrowhead Research Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Arrowhead Research Production and Growth Rate

Figure Arrowhead Research Market Revenue ($) Market Share 2015-2020

Table Gradalis Incorporated Company Profile

Table Gradalis Incorporated Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Gradalis Incorporated Production and Growth Rate

Figure Gradalis Incorporated Market Revenue ($) Market Share 2015-2020

Table Silenseed Company Profile

Table Silenseed Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Silenseed Production and Growth Rate

Figure Silenseed Market Revenue ($) Market Share 2015-2020

Table Silence Therapeutics Company Profile

Table Silence Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Silence Therapeutics Production and Growth Rate

Figure Silence Therapeutics Market Revenue ($) Market Share 2015-2020

Table Ensysce Biosciences Company Profile

Table Ensysce Biosciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ensysce Biosciences Production and Growth Rate

Figure Ensysce Biosciences Market Revenue ($) Market Share 2015-2020

Table GeneCopoeia Company Profile

Table GeneCopoeia Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GeneCopoeia Production and Growth Rate

Figure GeneCopoeia Market Revenue ($) Market Share 2015-2020

Table Creative Animodel Company Profile

Table Creative Animodel Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Creative Animodel Production and Growth Rate

Figure Creative Animodel Market Revenue ($) Market Share 2015-2020

Table Alnylam Pharmaceuticals Company Profile

Table Alnylam Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Alnylam Pharmaceuticals Production and Growth Rate

Figure Alnylam Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Roche Innovation Center Copenhagen (formerly Santaris Pharma) Company Profile

Table Roche Innovation Center Copenhagen (formerly Santaris Pharma) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Roche Innovation Center Copenhagen (formerly Santaris Pharma) Production and Growth Rate

Figure Roche Innovation Center Copenhagen (formerly Santaris Pharma) Market Revenue ($) Market Share 2015-2020

Table Ascletis Pharmaceuticals Company Profile

Table Ascletis Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ascletis Pharmaceuticals Production and Growth Rate

Figure Ascletis Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Sylentis Company Profile

Table Sylentis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sylentis Production and Growth Rate

Figure Sylentis Market Revenue ($) Market Share 2015-2020

Table Celsion Corporation Company Profile

Table Celsion Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Celsion Corporation Production and Growth Rate

Figure Celsion Corporation Market Revenue ($) Market Share 2015-2020

Table Calando Pharmaceuticals Company Profile

Table Calando Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Calando Pharmaceuticals Production and Growth Rate

Figure Calando Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Celgene Company Profile

Table Celgene Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Celgene Production and Growth Rate

Figure Celgene Market Revenue ($) Market Share 2015-2020

Table BioSpring Company Profile

Table BioSpring Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure BioSpring Production and Growth Rate

Figure BioSpring Market Revenue ($) Market Share 2015-2020

Table Global RNAi for Therapeutic Sales by Types (2015-2020)

Table Global RNAi for Therapeutic Sales Share by Types (2015-2020)

Table Global RNAi for Therapeutic Revenue ($) by Types (2015-2020)

Table Global RNAi for Therapeutic Revenue Share by Types (2015-2020)

Table Global RNAi for Therapeutic Price ($) by Types (2015-2020)

Table Global RNAi for Therapeutic Market Forecast Sales by Types (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Sales Share by Types (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue ($) by Types (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue Share by Types (2020-2025)

Figure Global siRNA Sales and Growth Rate (2015-2020)

Figure Global siRNA Price (2015-2020)

Figure Global miRNA Sales and Growth Rate (2015-2020)

Figure Global miRNA Price (2015-2020)

Figure Global shRNA Sales and Growth Rate (2015-2020)

Figure Global shRNA Price (2015-2020)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of siRNA (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of siRNA (2020-2025)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of miRNA (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of miRNA (2020-2025)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of shRNA (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of shRNA (2020-2025)

Table Global RNAi for Therapeutic Sales by Applications (2015-2020)

Table Global RNAi for Therapeutic Sales Share by Applications (2015-2020)

Table Global RNAi for Therapeutic Revenue ($) by Applications (2015-2020)

Table Global RNAi for Therapeutic Revenue Share by Applications (2015-2020)

Table Global RNAi for Therapeutic Market Forecast Sales by Applications (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Sales Share by Applications (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue ($) by Applications (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Cancer Sales and Growth Rate (2015-2020)

Figure Global Cancer Price (2015-2020)

Figure Global Cardiovascular Sales and Growth Rate (2015-2020)

Figure Global Cardiovascular Price (2015-2020)

Figure Global HBV Sales and Growth Rate (2015-2020)

Figure Global HBV Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of Cancer (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of Cancer (2020-2025)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of Cardiovascular (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of Cardiovascular (2020-2025)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of HBV (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of HBV (2020-2025)

Figure Global RNAi for Therapeutic Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Table Global RNAi for Therapeutic Sales by Regions (2015-2020)

Table Global RNAi for Therapeutic Sales Market Share by Regions (2015-2020)

Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2019

Figure Global RNAi for Therapeutic Revenue and Growth Rate (2015-2020)

Table Global RNAi for Therapeutic Revenue by Regions (2015-2020)

Table Global RNAi for Therapeutic Revenue Market Share by Regions (2015-2020)

Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2019

Table Global RNAi for Therapeutic Market Forecast Sales by Regions (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Sales Share by Regions (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue ($) by Regions (2020-2025)

Table Global RNAi for Therapeutic Market Forecast Revenue Share by Regions (2020-2025)

Figure North America RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure North America RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

Figure North America RNAi for Therapeutic Market Forecast Sales (2020-2025)

Figure North America RNAi for Therapeutic Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Canada RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Mexico RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Europe RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Europe RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

Figure Europe RNAi for Therapeutic Market Forecast Sales (2020-2025)

Figure Europe RNAi for Therapeutic Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure United Kingdom RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure France RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Italy RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Spain RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Russia RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Market Forecast Sales (2020-2025)

Figure Asia-Pacific RNAi for Therapeutic Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Japan RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure South Korea RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Australia RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure India RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure South America RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure South America RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

Figure South America RNAi for Therapeutic Market Forecast Sales (2020-2025)

Figure South America RNAi for Therapeutic Market Forecast Revenue ($) (2020-2025)

Figure Brazil RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Argentina RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Columbia RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa RNAi for Therapeutic Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa RNAi for Therapeutic Market Forecast Sales (2020-2025)

Figure Middle East and Africa RNAi for Therapeutic Market Forecast Revenue ($) (2020-2025)

Figure UAE RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure Egypt RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

Figure South Africa RNAi for Therapeutic Market Sales and Growth Rate (2015-2020)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370